The EPIC-Norfolk Study
Zuo H, Ueland PM, Midttun Ø, Vollset SE, Tell GS, Theofylaktopoulou D, Travis RC, Boutron-Ruault MC, Fournier A, Severi G, Kvaskoff M, Boeing H, Bergmann MM, Fortner RT, Kaaks R, Trichopoulou A, Kotanidou A, Lagiou P, Palli D, Sieri S, Panico S, Bueno-de-Mesquita HB, Peeters PH, Grankvist K, Johansson M, Agudo A, García JRQ, Larrañaga N, Sánchez MJ, Chirlaque MD, Ardanaz E, Chuang SC, Gallo V, Brennan P, and Ulvik A
Cancer research. Jun 2017
(DOI : 10.1158/0008-5472.CAN-17-1923)
A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.
Aleksandrova K, Chuang SC, Boeing H, Zuo H, Tell GS, Pischon T, Jenab M, Bueno-de-Mesquita B, Vollset SE, Midttun Ø, Ueland PM, Fedirko V, Johansson M, Weiderpass E, Severi G, Racine A, Boutron-Ruault MC, Kaaks R, Kühn T, Tjønneland A, Overvad K, Quirós JR, Jakszyn P, Sánchez MJ, Dorronsoro M, Chirlaque MD, Ardanaz E, Khaw KT, Wareham NJ, Travis RC, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, May AM, Palmqvist R, Ljuslinder I, Kong SY, Freisling H, Gunter MJ, Lu Y, Cross AJ, Riboli E, and Vineis P
Journal of the National Cancer Institute. Feb 2015
(DOI : 10.1093/jnci/djv010)